145 related articles for article (PubMed ID: 38146645)
1. Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.
Kozai H; Ogino H; Mitsuhashi A; Nguyen NT; Tsukazaki Y; Yabuki Y; Ozaki R; Yoneda H; Sato S; Hanibuchi M; Shinohara T; Nokihara H; Nishioka Y
Thorac Cancer; 2024 Feb; 15(5):369-378. PubMed ID: 38146645
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.
Furukawa R; Inoue H; Yoneshima Y; Tsutsumi H; Iwama E; Ikematsu Y; Ando N; Shiraishi Y; Ota K; Tanaka K; Nakanishi Y; Okamoto I
Lung Cancer; 2021 May; 155():144-150. PubMed ID: 33819860
[TBL] [Abstract][Full Text] [Related]
3. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
[TBL] [Abstract][Full Text] [Related]
4. Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade.
Cullen JK; Yap PY; Ferguson B; Bruce ZC; Koyama M; Handoko H; Hendrawan K; Simmons JL; Brooks KM; Johns J; Wilson ES; de Souza MMA; Broit N; Stewart P; Shelley D; McMahon T; Ogbourne SM; Nguyen TH; Lim YC; Pagani A; Appendino G; Gordon VA; Reddell PW; Boyle GM; Parsons PG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38658031
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer.
Li S; Wang S; Zhang A; Luo L; Song J; Wei G; Fang Z
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38391053
[TBL] [Abstract][Full Text] [Related]
6. PI3Kα inhibitor GNE-493 triggers antitumor immunity in murine lung cancer by inducing immunogenic cell death and activating T cells.
Xue X; Ye G; Zhang L; Zhu X; Liu Q; Rui G; Geng G; Lin Y; Chen X
Int Immunopharmacol; 2024 Mar; 130():111747. PubMed ID: 38442576
[TBL] [Abstract][Full Text] [Related]
7. The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy.
Zhang Y; Akhil V; Seo HS; Park HR; Kim SH; You SH; Liu Z; Kim SY; Sultonova RD; Min JJ; Hong Y
Theranostics; 2024; 14(3):1195-1211. PubMed ID: 38323311
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic cell death after combined treatment with radiation and ATR inhibitors is dually regulated by apoptotic caspases.
Eek Mariampillai A; Hauge S; Kongsrud K; Syljuåsen RG
Front Immunol; 2023; 14():1138920. PubMed ID: 37346039
[TBL] [Abstract][Full Text] [Related]
9.
Araki K; Yamamuro N; Tomonobu N; Kumon H
Anticancer Res; 2021 Oct; 41(10):4837-4855. PubMed ID: 34593432
[TBL] [Abstract][Full Text] [Related]
10. High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study.
Sumiyoshi I; Okabe T; Togo S; Takagi H; Motomura H; Ochi Y; Shimada N; Haraguchi M; Shibayama R; Fujimoto Y; Watanabe J; Iwai M; Kadoya K; Iwakami SI; Takahashi K
J Transl Med; 2021 Feb; 19(1):92. PubMed ID: 33639962
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Hodge JW; Garnett CT; Farsaci B; Palena C; Tsang KY; Ferrone S; Gameiro SR
Int J Cancer; 2013 Aug; 133(3):624-36. PubMed ID: 23364915
[TBL] [Abstract][Full Text] [Related]
12. Light-enhanced VEGF
Longva AS; Berg K; Weyergang A
Front Immunol; 2023; 14():1278000. PubMed ID: 38173721
[TBL] [Abstract][Full Text] [Related]
13. CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice.
Sakakibara K; Sato T; Kufe DW; VonHoff DD; Kawabe T
Oncotarget; 2017 Oct; 8(45):78277-78288. PubMed ID: 29108228
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Cell Oncol (Dordr); 2020 Dec; 43(6):1203-1214. PubMed ID: 32797385
[TBL] [Abstract][Full Text] [Related]
15. S-1 eliminates MDSCs and enhances the efficacy of PD-1 blockade via regulation of tumor-derived Bv8 and S100A8 in thoracic tumor.
Nguyen NT; Mitsuhashi A; Ogino H; Kozai H; Yoneda H; Afroj T; Sato S; Nokihara H; Shinohara T; Nishioka Y
Cancer Sci; 2023 Feb; 114(2):384-398. PubMed ID: 36285504
[TBL] [Abstract][Full Text] [Related]
16. (-)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer.
Yang X; Yang J; Gu X; Tao Y; Ji H; Miao X; Shen S; Zang H
Mol Cell Biochem; 2023 Jul; 478(7):1611-1620. PubMed ID: 36441354
[TBL] [Abstract][Full Text] [Related]
17. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells.
Calvet CY; Famin D; André FM; Mir LM
Oncoimmunology; 2014; 3():e28131. PubMed ID: 25083316
[TBL] [Abstract][Full Text] [Related]
18. MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells.
Limagne E; Nuttin L; Thibaudin M; Jacquin E; Aucagne R; Bon M; Revy S; Barnestein R; Ballot E; Truntzer C; Derangère V; Fumet JD; Latour C; Rébé C; Bellaye PS; Kaderbhaï CG; Spill A; Collin B; Callanan MB; Lagrange A; Favier L; Coudert B; Arnould L; Ladoire S; Routy B; Joubert P; Ghiringhelli F
Cancer Cell; 2022 Feb; 40(2):136-152.e12. PubMed ID: 35051357
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma.
Gao X; Huang H; Pan C; Mei Z; Yin S; Zhou L; Zheng S
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230638
[TBL] [Abstract][Full Text] [Related]
20. Pulsatilla Decoction Combined with 5-Fluorouracil Triggers Immunogenic Cell Death in Colorectal Cancer Cells.
Jie Y; Yang X; Chen W
Cancer Biother Radiopharm; 2022 Dec; 37(10):945-954. PubMed ID: 34042519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
